MARKET

CRSP

CRSP

Crispr Therapeut
NASDAQ
50.23
+0.79
+1.60%
After Hours: 50.44 +0.21 +0.42% 19:55 06/11 EDT
OPEN
50.09
PREV CLOSE
49.44
HIGH
51.14
LOW
49.02
VOLUME
1.51M
TURNOVER
--
52 WEEK HIGH
78.48
52 WEEK LOW
39.81
MARKET CAP
4.84B
P/E (TTM)
-8.0874
1D
5D
1M
3M
1Y
5Y
1D
Private Markets: Bezos’ Prometheus raises $12B as OpenAI files for IPO
TipRanks · 14h ago
Crispr Therapeutics assumed at Equal Weight from Underweight at Morgan Stanley
TipRanks · 22h ago
Analysts Offer Insights on Healthcare Companies: Crispr Therapeutics AG (CRSP) and Hinge Health, Inc. Class A (HNGE)
TipRanks · 23h ago
Crispr Therapeutics AG (CRSP) Gets a Buy from Mizuho Securities
TipRanks · 1d ago
Weekly Report: what happened at CRSP last week (0601-0605)?
Weekly Report · 3d ago
Shareholders Approve New Incentive Plan and Governance Measures
TipRanks · 06/04 22:52
Notable Thursday Option Activity: FIVE, CRSP, LQDA
NASDAQ · 06/04 20:13
Where short sellers are betting across mid- and large-cap stocks
Seeking Alpha · 06/04 13:35
More
About CRSP
CRISPR Therapeutics AG is a Switzerland-based gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and is a technology for gene editing, the process of precisely altering specific sequences of genomic DNA. The Company aims to apply this technology to disrupt, delete, correct and insert genes to treat genetically-defined diseases and to engineer advanced cellular therapies. The Company has acquired the rights to the intellectual property (IP) encompassing CRISPR/Cas9 and related technologies and is also involved in its own IP research and additional in-licensing efforts. The Company product development and partnership strategies are designed to exploit the full potential of the CRISPR/Cas9 platform while maximizing the probability of successfully developing their product candidates.

Webull offers Crispr Therapeutics AG stock information, including NASDAQ: CRSP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRSP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRSP stock methods without spending real money on the virtual paper trading platform.